Reaction

Pneumonia Pneumococcal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,461 reports · 45 co-occurring drugs

As of the last recalculation, Pneumonia Pneumococcal appears in 1,461 FAERS reports alongside 45 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 27.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Valganciclovir Hydrochloride Powder,	23	27.3	27.3
Selinexor	12	19.9	19.9
Valganciclovir	24	18.4	18.4
Valganciclovir Hydrochloride	24	18.4	18.4
Daratumumab	47	17.3	17.3
Sirolimus	15	16.0	16.0
Bortezomib	89	15.0	15.0
Baricitinib	10	14.9	14.9
Amphotericin B	12	13.7	13.8
Lopinavir And Ritonavir	11	11.6	11.7
Tenofovir Disoproxil Fumarate Tablets	7	11.6	11.6
Efavirenz	9	11.6	11.6
Melphalan	18	11.4	11.4
Darunavir	12	11.4	11.4
Itraconazole	9	11.0	11.0
Melphalan Hydrochloride	19	10.9	10.9
Atovaquone	6	10.7	10.7
Raltegravir	12	10.4	10.4
Carfilzomib	20	10.2	10.2
Ceftriaxone Sodium	27	10.2	10.2
Ceftriaxone	23	10.1	10.1
Tacrolimus Ointment 0.1%	83	10.0	10.0
Tacrolimus Extended-Release Capsules	83	10.0	10.0
Tacrolimus	101	9.8	9.8
Ganciclovir	7	9.8	9.8
Mycophenilic Acid	14	9.7	9.7
Ritonavir 100 Mg	10	9.6	9.6
Ganciclovir Sodium	7	9.5	9.5
Thalidomide	23	9.1	9.1
Dexamethasone 1.5 Mg	167	9.0	9.0
Oseltamivir	5	9.0	9.0
Dexamethasone	167	8.9	8.9
Remdesivir	8	8.6	8.6
Lamivudine Oral	15	8.5	8.5
Busulfan	9	8.2	8.2
Cyclophosphamide Injection, Solution	86	7.3	7.3
Cyclophosphamide	86	7.3	7.3
Cyclophosphamide For Injection	86	7.3	7.3
Pomalidomide	47	6.7	6.7
Ixazomib	13	6.5	6.5
Bendamustine Hydrochloride	5	6.0	6.0
Oseltamivir Phosphate	10	5.9	5.9
Tenofovir Disoproxil Fumarate	12	5.2	5.2
Benralizumab	7	5.0	5.0
Lenalidomide	105	3.7	3.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.